Clinical Trial Update: Plasmafit® Revision Structan® Hip Endoprosthesis Cup

View source ↗

Summary

The Plasmafit Revision Structan Hip Endoprosthesis Cup by Aesculap AG is listed as an active, not-recruiting clinical trial for hip-related conditions including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroplasty Complications
• Avascular Necrosis of the Femoral Head
• Hip Fracture
• Instability of Prosthetic Joint
• Osteoarthritis
• Osteolysis
• Prosthesis Failure
• Rheumatoid Arthritis

Drugs mentioned

• Plasmafit Revision Structan Hip Endoprosthesis Cup

Snippet

Sponsor: Aesculap AG | Conditions: Osteolysis, Arthroplasty Complications | Status: ACTIVE_NOT_RECRUITING